Skip to Main Content

Author Details

Joel N Swerdel
Janssen Research & Development LLC
1982
34
13
PMIDPaper TitleJournal TitlePublished Year
36795690Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosus.PLoS One2023
36396894Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms' Fit for Purpose for Safety Outcomes.Drug Saf2023
36826399Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study.J Am Med Inform Assoc2023
35995107PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation.J Biomed Inform2022
37632892Phenotype Algorithms to Identify Hidradenitis Suppurativa Using Real-World Data: Development and Validation Study.JMIR Dermatol2022
35728447Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis.Semin Arthritis Rheum2022
35790044Performance characteristics of code-based algorithms to identify urinary tract infections in large United States administrative claims databases.Pharmacoepidemiol Drug Saf2022
35753071Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease.Pharmacoepidemiol Drug Saf2022
33830834Incidence rate of hospitalization and mortality in the first year following initial diagnosis of cardiac amyloidosis in the US claims databases.Curr Med Res Opin2021
32500272Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen.Drug Saf2020
31939079Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets.Drug Saf2020
31642211Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts.Korean Circ J2020
33024121Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.Nat Commun2020
33240487Evaluation of code-based algorithms to identify pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in large administrative databases.Pulm Circ2020
32338068Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study.Curr Med Res Opin2020
31369862PheValuator: Development and evaluation of a phenotype algorithm evaluator.J Biomed Inform2019
27212039Association Between Dehydration and Short-Term Risk of Ischemic Stroke in Patients with Atrial Fibrillation.Transl Stroke Res2017
28780741Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications.Drug Saf2017
27817795Frequency of Stroke After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting (from an Eleven-Year Statewide Analysis).Am J Cardiol2017
27080323Work-Related Unintentional Injuries Associated With Hurricane Sandy in New Jersey.Disaster Med Public Health Prep2016
26654113Rates of Hospitalization for Dehydration Following Hurricane Sandy in New Jersey.Disaster Med Public Health Prep2016
27881427Ischemic Stroke Rate Increases in Young Adults: Evidence for a Generational Effect?J Am Heart Assoc2016
25645156Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.Catheter Cardiovasc Interv2015
24388619Competing cardiovascular and noncardiovascular risks and longevity in the systolic hypertension in the elderly program.Am J Cardiol2014
25488295The effect of Hurricane Sandy on cardiovascular events in New Jersey.J Am Heart Assoc2014
25368403Cancer death and antihypertensive drug treatment-response.Cancer Epidemiol Biomarkers Prev2014
24832873Rapid decreases in blood pressure from antihypertensive treatment were associated with increased cancer mortality in the Systolic Hypertension in the Elderly Program.Cancer Epidemiol Biomarkers Prev2014
1711608Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.J Cardiovasc Pharmacol1991
1696660Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats.J Cardiovasc Pharmacol1990
2139545Role of atrial natriuretic peptide in sodium balance in conscious spontaneously hypertensive rats.Am J Physiol1990
2544529Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.Hypertension1989
2476591Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopeptidase.J Cardiovasc Pharmacol1989
2974913Atrial natriuretic peptides cleaved by endopeptidase are inactive in conscious spontaneously hypertensive rats.Life Sci1988
6128380Endotoxin-induced changes in copper and zinc metabolism in the Syrian hamster.J Nutr1982
  • 1 - 34 of 34

Recommended Authors

Center for Outcomes Research and Evaluation, Yale-New Haven Hospital
Career Start Year 2017
Number of shared co-authors 0
School of Public Health, University of Alabama at Birmingham
Career Start Year 2015
Number of shared co-authors 0
Griffin Hospital
Career Start Year 2012
Number of shared co-authors 1
Clinical and Translational Research Accelerator, Yale University
Career Start Year 2012
Number of shared co-authors 0
USA Tempus Labs Inc.
Career Start Year 2012
Number of shared co-authors 17
Harvard Medical School
Career Start Year 2011
Number of shared co-authors 6
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 3
Lahey Hospital and Medical Center
Career Start Year 2010
Number of shared co-authors 1
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 0
University of Utah School of Medicine
Career Start Year 2009
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 2009
Number of shared co-authors 11
Cardiovascular Health Research Unit, University of Washington
Career Start Year 2008
Number of shared co-authors 1
University of Michigan School of Medicine ann arbor
Career Start Year 2006
Number of shared co-authors 0
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2006
Number of shared co-authors 6
Harvard Medical School
Career Start Year 2006
Number of shared co-authors 0
Saint Luke's Mid America Heart Institute
Career Start Year 2004
Number of shared co-authors 1
Wayne State University School of Medicine.
Career Start Year 2003
Number of shared co-authors 0
Ben Gurion University
Career Start Year 2003
Number of shared co-authors 0
Rutgers University Institute for Health, the State University of New Jersey
Career Start Year 2001
Number of shared co-authors 4
Department of Quantitative Health Sciences Mayo Clinic Rochester MN USA.
Career Start Year 1999
Number of shared co-authors 1
Duke Clinical Research Institute
Career Start Year 1999
Number of shared co-authors 2
University of California-San Francisco
Career Start Year 1998
Number of shared co-authors 2
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 6
University of Florida
Career Start Year 1995
Number of shared co-authors 2
Geisel School of Medicine at Dartmouth
Career Start Year 1992
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 1988
Number of shared co-authors 29
Weill Cornell Medical College
Career Start Year 1987
Number of shared co-authors 1
Kaiser Permanente Northern California
Career Start Year 1962
Number of shared co-authors 1
Clinical and Translational Research Accelerator, Yale University School of Medicine
Career Start Year 1949
Number of shared co-authors 0

Collaborators

Columbia University Irving Medical Center
Co-authored papers 9
University of California los angeles
Co-authored papers 6
Janssen Pharmaceutical Research & Development
Co-authored papers 4
Columbia University
Co-authored papers 4
Janssen Pharmaceutical Research and Development
Co-authored papers 3
Rutgers University School of Public Health
Co-authored papers 3
University of California los angeles
Co-authored papers 3
Janssen Pharmaceutical Research & Development
Co-authored papers 2
Georgia State University
Co-authored papers 2
University of Oxford
Co-authored papers 2
Bayer Pharmaceuticals
Co-authored papers 2
Yonsei University College of Medicine
Co-authored papers 2
Erasmus University Medical Center
Co-authored papers 2
Janssen Pharmaceutical Research and Development LLC
Co-authored papers 2
University of Oxford
Co-authored papers 2
University of Oxford
Co-authored papers 2
University of Utah Health
Co-authored papers 2
Janssen Pharmaceutical Research and Development
Co-authored papers 2
Queen Mary University of London
Co-authored papers 2
Erasmus University Medical Center
Co-authored papers 2
Ajou University Graduate School of Medicine
Co-authored papers 2
University of Utah
Co-authored papers 2
Rush University Medical Center
Co-authored papers 2
Northeastern University
Co-authored papers 2
Yonsei University College of Medicine
Co-authored papers 2
Erasmus University Medical Center
Co-authored papers 1
Islamic University of Gaza
Co-authored papers 1
Peking University Third Hospital.
Co-authored papers 1
Columbia University Irving Medical Center
Co-authored papers 1
Universidad del Norte
Co-authored papers 1